And Then There Were Three: Woodcock Offers Another Explanation For Aduhelm’s Labeling Fiasco

 
• By Sarah Karlin-Smith
  
broad horizon
Woodcock said it is standard policy for the Office of Neuroscience to issue broad labels. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Agency Leadership

More from Pink Sheet